RecruitingNCT06798636
Psilocybin-assisted imagery therapy for young people who self-harm
About this title
PsiloIMAGINE: A Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm
Read the official source — NCT06798636Medication studyAges 16–25United KingdomSuicide prevention
Understand this study
Who could participate?
Listed age limits: 16 years to 25 years.
- Listed locations
- LondonSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 1, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 30
- Sponsor
- Imperial College London
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United Kingdom
- Age range
- From 16 Years to 25 Years
- Official registry ID
- NCT06798636
- Official title
Show the full official title
Investigating the Effects of a Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm Behaviour: an Experimental Medicine Study
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
London
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Imperial College London, a university.
Who can participate?
Listed age limits: 16 years to 25 years.
Is this study still recruiting?
The registry lists this study as recruiting.
